Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|4|346-359

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.4, 2016-02, pp. : 346-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease

By Korczyn A.D.   Nussbaum M.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Parkinson’s disease

By Tuite Paul   Riss Jennifer  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1335-1352

Informa Healthcare

Access to resources Recommend Favorite

New directions in Parkinson’s research and treatment

By Napolitano A.   Pezzella A.   Misuraca G.   Prota G.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1251-1268

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotection for Parkinson’s disease: a new approach for a new millennium

By Drukarch Benjamin   van Muiswinkel Freek L  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1855-1868

Informa Healthcare

Access to resources Recommend Favorite

Ropinirole in the treatment of Parkinson’s disease

By Zesiewicz T.A.   Hauser R.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite